Skip to main content
. Author manuscript; available in PMC: 2018 Feb 16.
Published in final edited form as: Health Promot Pract. 2016 Aug 19;18(2):283–289. doi: 10.1177/1524839916661495

TABLE 2.

Summary of Intervention Design by Site

Site Patient inclusion criteria Outreach methodology Randomization
1 Patients born between 1945 and 1965 who had previously visited a site 1 clinic and who had no prior evidence of HCV testing in their medical records In-person recruitment by study coordinators at four internal medicine clinics Cluster randomized crossover design: two intervention clinics and two control clinics which switched midway through the study (Rietbergen & Moerbeek, 2011)
2 Patients identified in the EHR system born between 1945 and 1965 who had made at least one primary care visit to a system-affiliated physician in the past year and who had no prior evidence of HCV testing in their medical records Repeated mailing outreach at weeks 0, 1, 4, 8, and 12, based on a Dillman Total Design Survey Method (Hoddinott & Bass, 1986) Stratified multiclinic, individually randomized—within each clinic, patients were randomized to intervention or control
3 Patients born between 1945 and 1965 and who had no prior evidence of HCV testing in their medical records EHR best practice alert targeted to medical assistants indicating patients eligible for a test Cluster randomized design among 10 semiautonomous primary care practices

NOTE: HCV = hepatitis C virus; EHR = electronic health record.